- Home
- KRMD vs CCIF Comparison
KRMD vs CCIF Comparison
Compare KRMD & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- CCIF
- Stock Information
- Founded
- KRMD 1980
- CCIF 2011
- Country
- KRMD United States
- CCIF United States
- Employees
- KRMD N/A
- CCIF N/A
- Industry
- KRMD Medical/Dental Instruments
- CCIF Finance/Investors Services
- Sector
- KRMD Health Care
- CCIF Finance
- Exchange
- KRMD Nasdaq
- CCIF Nasdaq
- Market Cap
- KRMD 134.3M
- CCIF 121.4M
- IPO Year
- KRMD N/A
- CCIF N/A
- Fundamental
- Price
- KRMD $4.04
- CCIF $5.66
- Analyst Decision
- KRMD Strong Buy
- CCIF
- Analyst Count
- KRMD 4
- CCIF 0
- Target Price
- KRMD $4.63
- CCIF N/A
- AVG Volume (30 Days)
- KRMD 63.4K
- CCIF 76.9K
- Earning Date
- KRMD 11-12-2025
- CCIF 01-01-0001
- Dividend Yield
- KRMD N/A
- CCIF 25.90%
- EPS Growth
- KRMD N/A
- CCIF N/A
- EPS
- KRMD N/A
- CCIF N/A
- Revenue
- KRMD $36,848,451.00
- CCIF N/A
- Revenue This Year
- KRMD $21.08
- CCIF N/A
- Revenue Next Year
- KRMD $16.37
- CCIF N/A
- P/E Ratio
- KRMD N/A
- CCIF N/A
- Revenue Growth
- KRMD 19.57
- CCIF N/A
- 52 Week Low
- KRMD $1.86
- CCIF $7.43
- 52 Week High
- KRMD $5.05
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- KRMD 52.39
- CCIF 45.84
- Support Level
- KRMD $3.87
- CCIF $5.65
- Resistance Level
- KRMD $4.12
- CCIF $5.91
- Average True Range (ATR)
- KRMD 0.14
- CCIF 0.13
- MACD
- KRMD -0.03
- CCIF 0.02
- Stochastic Oscillator
- KRMD 45.24
- CCIF 43.50
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.